Lv3
220 积分 2025-07-09 加入
Abstract P3-11-08: Eribulin/cyclophosphamide (ErC) versus docetaxel/cyclophosphamide (TC) as neoadjuvant therapy in locally advanced HER2-negative breast cancer: A randomized phase II trial of the Sarah Cannon Research Institute
16小时前
求助中
乳腺良性硬化性病变基础上发生的低级别腺鳞癌临床病理学分析
1个月前
已完结
Clinicopathologic characteristics of HER2-positive metaplastic squamous cell carcinoma of the breast
1个月前
已完结
乳腺化生性鳞状细胞癌临床病理特征及HER2表达情况分析
1个月前
已完结
乳腺鳞状细胞癌临床病理特征及其免疫微环境分析
1个月前
已完结
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
3个月前
已完结
Longitudinal Assessment of Tumor-Infiltrating Lymphocytes in Primary Breast Cancer Following Neoadjuvant Radiation Therapy
3个月前
已完结
An Unusual Occurrence of Synchronous Squamous Cell Carcinoma and Invasive Ductal Carcinoma in the Ipsilateral Breast: A Case Report
4个月前
已完结
皖公网安备34019202002308
